The CX6 series includes a concentrated, one-spot, mass delivery to maximize the high reactivity of nanozyme. This technology, which utilizes nanocarriers optimized for the delivery, is effective in treating acute diseases.
The best physical and chemical effects can be induced by encapsulating a large amount of nanozyme while maintaining the nanoscale. This approach is optimized for acute diseases that require immediate high therapeutic effects.
Nanozymes are quickly excreted out of the body, and the nanocarrier applied to Nanobomb consists of biodegradable materials. This combination of rapid excretion and degradation ensures nanozyme technology is extremely safe.
Nanozymes and nanocarriers can provide more flexible physicochemical properties. Various properties can be applied depending on the disease, and disease-specific materials can be introduced easily.
Cenyx Biotech has developed a variety of nanozyme and nanocarrier technologies using CX platform technology. This enables a variety of medicine and carrier combinations, and promises high scalability.